Benitec Stock Buy Hold or Sell Recommendation

BNTC
 Stock
  

USD 0.17  0.0057  3.56%   

Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Benitec Biopharma is 'Strong Sell'. Macroaxis provides Benitec Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BNTC positions. The advice algorithm takes into account all of Benitec Biopharma's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Benitec Biopharma's buy-and-hold perspective. Continue to Benitec Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Benitec and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Benitec Biopharma.

Execute Benitec Biopharma Buy or Sell Advice

The Benitec recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Benitec Biopharma. Macroaxis does not own or have any residual interests in Benitec Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Benitec Biopharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Benitec BiopharmaBuy Benitec Biopharma
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Reporting Quality (M-Score)

Details
For the selected time horizon Benitec Biopharma has a Mean Deviation of 5.71, Standard Deviation of 8.42 and Variance of 70.91
We provide trade advice to complement the prevailing expert consensus on Benitec Biopharma. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Benitec Biopharma is not overpriced, please confirm all Benitec Biopharma fundamentals, including its price to book, total debt, number of employees, as well as the relationship between the ebitda and cash flow from operations . As Benitec Biopharma appears to be a penny stock we also recommend to validate its price to earning numbers.

Benitec Biopharma Trading Alerts and Improvement Suggestions

Benitec Biopharma generated a negative expected return over the last 90 days
Benitec Biopharma has high historical volatility and very poor performance
Benitec Biopharma has some characteristics of a very speculative penny stock
Benitec Biopharma has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 73 K. Net Loss for the year was (18.21 M) with profit before overhead, payroll, taxes, and interest of 64 K.
Benitec Biopharma currently holds about 4.06 M in cash with (15.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 58.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Insiders who placed huge bets on Benitec Biopharma Inc. earlier this year would be disappointed with the 12 percent drop - Simply Wall St

Benitec Biopharma Returns Distribution Density

The distribution of Benitec Biopharma's historical returns is an attempt to chart the uncertainty of Benitec Biopharma's future price movements. The chart of the probability distribution of Benitec Biopharma stock daily returns describes the distribution of returns around its average expected value. We use Benitec Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Benitec Biopharma returns is essential to provide solid investment advice for Benitec Biopharma.
Mean Return-1.5Value At Risk-13.51
Potential Upside10.53Standard Deviation8.42
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Benitec Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Benitec Biopharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Benitec Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Benitec Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Benitec stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-1.58
β
Beta against NYSE Composite1.30
σ
Overall volatility
6.92
Ir
Information ratio -0.19

Benitec Biopharma Volatility Alert

Benitec Biopharma is displaying above-average volatility over the selected time horizon. Investors should scrutinize Benitec Biopharma independently to ensure intended market timing strategies are aligned with expectations about Benitec Biopharma volatility. Benitec Biopharma is a potential penny stock. Although Benitec Biopharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Benitec Biopharma. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Benitec instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Benitec Biopharma Fundamentals Vs Peers

Comparing Benitec Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Benitec Biopharma's direct or indirect competition across all of the common fundamentals between Benitec Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Benitec Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Benitec Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Benitec Biopharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Benitec Biopharma to competition
FundamentalsBenitec BiopharmaPeer Average
Return On Equity(1.21) %(0.31) %
Return On Asset(0.61) %(0.14) %
Operating Margin(241.26) %(5.51) %
Current Valuation(10.47 M)16.62 B
Shares Outstanding27.98 M571.82 M
Shares Owned by Insiders7.90 %10.09 %
Shares Owned by Institutions58.39 %39.21 %
Number of Shares Shorted165.18 K4.71 M
Price to Earning(5.10) X28.72 X
Price to Book0.36 X9.51 X
Price to Sales63.67 X11.42 X
Revenue73 K9.43 B
Gross Profit64 K27.38 B
EBITDA(17.78 M)3.9 B
Net Income(18.21 M)570.98 M
Cash and Equivalents4.06 M2.7 B
Cash per Share0.50 X5.01 X
Total Debt811 K5.32 B
Debt to Equity0.28 %48.70 %
Current Ratio1.90 X2.16 X
Book Value Per Share0.57 X1.93 K
Cash Flow from Operations(15.9 M)971.22 M
Short Ratio0.20 X4.00 X
Earnings Per Share(2.17) X3.12 X
Target Price4.0
Number of Employees1818.84 K
Beta1.21-0.15
Market Capitalization4.65 M19.03 B
Total Asset5.97 M29.47 B
Retained Earnings(137.17 M)9.33 B
Working Capital18.35 M1.48 B
Current Asset19.38 M9.34 B
Current Liabilities1.03 M7.9 B
   Acquisition by Peter Francis of 12000 shares of Benitec Biopharma subject to Rule 16b-3 [view details]

Benitec Biopharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Benitec . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Benitec Biopharma Buy or Sell Advice

When is the right time to buy or sell Benitec Biopharma? Buying financial instruments such as Benitec Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Benitec Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Conservative Thematic Idea Now

Conservative
Conservative Theme
Funds or Etfs that invest using buy-and-hold investment strategy in companies with consistent growth over many years of operation. The Conservative theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Conservative Theme or any other thematic opportunities.
View All  Next Launch
Continue to Benitec Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for analysis

When running Benitec Biopharma price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Benitec Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.6 M
Quarterly Revenue Growth YOY
(1.00) 
Return On Assets
(0.61) 
Return On Equity
(1.21) 
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Benitec Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.